| 标题 |
Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:BMC Medicine 作者:Xiao Zhao; Jing Zhang; Lupeng Qiu; Quanli Han; Xiang Yan; et al 出版日期:2025 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |